Literature DB >> 26556489

[Pathophysiology of implant-associated infections: From biofilm to osteolysis and septic loosening].

C Wagner1, G M Hänsch2.   

Abstract

Biofilm formation is the key factor in the pathogenesis of implant-associated infections. The most common pathogens isolated are Staphylococcus species, opportunists belonging to the physiological flora of the skin. Biofilm formation starts with the adhesion of bacteria and colonisation preferentially occurs on the surfaces of the foreign body material. As an interactive symbiotic "city of microbes," biofilm formation represents an efficient survival strategy for bacteria. In clinically apparent infections the biofilm induces a local host response with infiltration of phagocytic immune cells. The proinflammatory microenvironment results in a stimulation of osteoclastogenesis, with local osteolysis, and finally septic loosening of the implant. According to the biofilm theory, retaining the implant in primary revision surgery is only recommended in early-stage infections with a stable implant; in late-stage infections, or when loosening occurs, the implant should be removed. Results of previous anti-biofilm therapies have not been satisfactory; therefore, current research is focused on prevention strategies, especially the modification of implant surfaces. Basic knowledge of the underlying pathophysiology is a prerequisite for the development of innovative interdisciplinary therapy and prevention strategies; in this context, essential aspects of biofilm formation, its consequences, and its relevance to diagnosis and therapy are described and discussed.

Entities:  

Keywords:  Bacterial adhesion; Biofilms; Inflammation; Local immune response; Surface modification

Mesh:

Year:  2015        PMID: 26556489     DOI: 10.1007/s00132-015-3183-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  37 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Detection of biomaterial-associated infections in orthopaedic joint implants.

Authors:  Daniëlle Neut; Jim R van Horn; Theo G van Kooten; Henny C van der Mei; Henk J Busscher
Journal:  Clin Orthop Relat Res       Date:  2003-08       Impact factor: 4.176

Review 3.  Biofilm theory can guide the treatment of device-related orthopaedic infections.

Authors:  J William Costerton
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

Review 4.  The in vivo biofilm.

Authors:  Thomas Bjarnsholt; Maria Alhede; Morten Alhede; Steffen R Eickhardt-Sørensen; Claus Moser; Michael Kühl; Peter Østrup Jensen; Niels Høiby
Journal:  Trends Microbiol       Date:  2013-07-02       Impact factor: 17.079

Review 5.  [Revision strategy for periprosthetic infection].

Authors:  B Lehner; D Witte; A J Suda; S Weiss
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

Review 6.  Biofilm-specific antibiotic tolerance and resistance.

Authors:  I Olsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-29       Impact factor: 3.267

7.  Biomaterial-centered infection: microbial adhesion versus tissue integration.

Authors:  A G Gristina
Journal:  Science       Date:  1987-09-25       Impact factor: 47.728

Review 8.  Is aseptic loosening truly aseptic?

Authors:  Carl L Nelson; Alex C McLaren; Sandra G McLaren; Jeffrey W Johnson; Mark S Smeltzer
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

Review 9.  The future of biologic coatings for orthopaedic implants.

Authors:  Stuart B Goodman; Zhenyu Yao; Michael Keeney; Fan Yang
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

10.  Post-traumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection.

Authors:  Christof Wagner; Kai Kondella; Tobias Bernschneider; Volkmar Heppert; Andreas Wentzensen; G Maria Hänsch
Journal:  Shock       Date:  2003-12       Impact factor: 3.454

View more
  1 in total

1.  The antimicrobial peptide KR-12 promotes the osteogenic differentiation of human bone marrow stem cells by stimulating BMP/SMAD signaling.

Authors:  Hui Li; Shutao Zhang; Bin'en Nie; Zhe Du; Teng Long; Bing Yue
Journal:  RSC Adv       Date:  2018-04-24       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.